Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.69 USD | -1.13% | +1.48% | -5.06% |
05-03 | Arcellx Insider Sold Shares Worth $932,557, According to a Recent SEC Filing | MT |
04-18 | Arcellx Insider Sold Shares Worth $522,260, According to a Recent SEC Filing | MT |
Business Summary
Number of employees: 130
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Therapies
100.0
%
| 0 | nan % | 110 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 110 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21/01/21 |
Michelle Gilson
DFI | Director of Finance/CFO | 32 | 22/05/22 |
David Tice
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/03/20 |
Narinder Singh
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/09/21 |
Chief Tech/Sci/R&D Officer | 44 | 31/03/21 | |
Myesha Lacy
IRC | Investor Relations Contact | - | 31/05/21 |
General Counsel | - | 20/06/22 | |
Aileen Fernandes
PRN | Corporate Officer/Principal | - | 31/12/20 |
Kate Aiken
HRO | Human Resources Officer | - | 31/12/12 |
Neeraj Teotia
PRN | Corporate Officer/Principal | 49 | 31/03/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 31/07/20 |
Ali Behbahani
BRD | Director/Board Member | 47 | 31/01/15 |
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21/01/21 |
Jill Carroll
BRD | Director/Board Member | 48 | 31/08/17 |
Kavita Patel
BRD | Director/Board Member | 50 | 30/11/21 |
Derek Yoon
BRD | Director/Board Member | 49 | 31/03/20 |
Olivia Ware
BRD | Director/Board Member | 67 | 15/05/22 |
Hong Xia Wang
BRD | Director/Board Member | 48 | 30/04/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,290,315 | 41,889,893 ( 78.61 %) | 0 | 78.61 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.06% | 2.84B | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- ACLX Stock
- Company Arcellx, Inc.